AMGN vs BRK.B · P/E 24, rev $10.05B vs rev $371.44B
Amgen Inc (AMGN) versus BRK.B (BRK.B) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. BRK.B currently screens at market cap $0.
Not investment advice. Open the AMGN and BRK.B stock pages for the full models.
Not investment advice.